55
Dravite Therapeutics, Inc. raises $53M under Reg D
Company raise · Closed · Offering $53M · Sold $53M · SAN FRANCISCO, CA · filed 2026-09-03
52
Dravite Therapeutics, Inc. raises $15M under Reg D
Company raise · Closed · SAN FRANCISCO, CA · Form D filed 2026-06-24
$10M+ raiseFirst raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| JOSEPH SUM | Director |
| BARBARA KOSACZ | Director |
| MICHAEL MOORE | Executive Officer, Director |
| SANDEEP KULKARNI | Director |
Signed by Michael Moore, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
27
Dravite Therapeutics, Inc. files Form D
Company raise update · Closed · Offering $15M · Sold $15M · SAN FRANCISCO, CA · filed 2026-07-28